Oligometastatic Carcinoma — Trials

Oligometastatic Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 16
Recruiting: 7
Ph III recruiting: 1
Growth YoY: —
Industry share: 6%
Top sponsor: Mayo Clinic
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06389786	Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer	recruiting	N/A	50	Mayo ClinicOTHER	1	Apr 6, 2026	clinicaltrials
NCT06674863	Addressing Health Literacy With a Tailored Survivorship Care Plan	recruiting	N/A	150	Emory UniversityOTHER	1	Dec 9, 2025	clinicaltrials